HBM N news, videos and press releases - Page 5
For more news please use our advanced search feature.
HBM N - More news...
HBM N - More news...
- EQS-News: Key Figures 31.12.2021
- EQS-Adhoc: HBM Healthcare Investments delivers strong return despite weak biotech sector and increases net asset value per share (NAV) by 19 percent in calendar year 2021
- EQS-News: Key Figures 15.12.2021
- EQS-News: Key Figures 30.11.2021
- EQS-News: Key Figures 15.11.2021
- EQS-News: HBM Healthcare Investments benefits from the IPO of portfolio company IO Biotech
- EQS-News: Key Figures 31.10.2021
- EQS-Adhoc: HBM Healthcare Investments Half-year Report September 2021
- EQS-News: Key Figures 15.10.2021
- EQS-News: Key Figures 30.09.2021
- EQS-Adhoc: HBM Healthcare Investments achieves value growth of 12.6 percent in the first half of the 2021/2022 financial year
- EQS-News: Key Figures 15.09.2021
- EQS-News: Key Figures 31.08.2021
- EQS-News: Key Figures 15.08.2021
- EQS-News: Key Figures 31.07.2021
- HBM Presents Phase I Data on Next-Generation Anti-CTLA-4 Antibody at ESMO Congress 2021
- EQS-Adhoc: HBM Healthcare Investments Quarterly Report June 2021
- EQS-News: Key Figures 15.07.2021
- EQS-News: Key Figures 30.06.2021
- EQS-Adhoc: Successful IPO for HBM portfolio company Monte Rosa Therapeutics
- EQS-Adhoc: HBM portfolio company Ambrx Biopharma raises USD 126 million in initial public offering on New York Stock Exchange
- EQS-Adhoc: Shareholders' Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
- EQS-Adhoc: HBM Healthcare Investments has ended the subscription period for the bond early and increased the issue amount to CHF 100 million
- EQS-News: Key Figures 15.06.2021
- EQS-Adhoc: HBM Healthcare Investments Ltd announces the issue of a bond with a 6-year term and a minimum issue amount of CHF 60 million
- EQS-Adhoc: Tata Digital to acquire majority stake in HBM portfolio company 1mg, India's leading digital healthcare platform
- EQS-Adhoc: HBM portfolio company Valo Health and Khosla Ventures Acquisition Co. to combine and create publicly traded company
- EQS-Adhoc: Key Figures 31.05.2021
- EQS-Adhoc: HBM portfolio company Swixx BioPharma announces EUR 45 million capital increase
- EQS-Adhoc: Publication of Annual Report 2020/2021 and Invitation to the Ordinary Shareholders' Meeting
